Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke

NCT06801457 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06801457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06801457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
January 30, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke acute